Article info
PDFNeuromuscular
Original research
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions
- Correspondence to Prof. Massimiliano Filosto, Department of Clinical and Experimental Sciences, University of Brescia; Unit of Neurology, ASST Spedali Civili; NeMO-Brescia Clinical Center for Neuromuscular Diseases, Brescia, Italy; massimiliano.filosto{at}unibs.it
Citation
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions
Publication history
- Received August 14, 2020
- Revised October 17, 2020
- Accepted October 17, 2020
- First published November 6, 2020.
Online issue publication
January 16, 2022
Article Versions
- Previous version (14 June 2021).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage